Last 45 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -25.15 | — | — | — | 16.92 | 15.86 | 23.72 | 38.00 | 48.29 | 27.06 | 14.44 | 31.20 | 6.26 | 32.14 | — | — | — | — | — | — | 151.00 |
| — | — | — | — | -65.0% | -41.4% | +64.3% | +21.8% | +670.9% | -15.8% | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.59 | 2.73 | 2.21 | 2.48 | 2.15 | 2.30 | 2.31 | 3.22 | 3.86 | 2.61 | 2.96 | 3.41 | 3.74 | 2.66 | 2.36 | 1.36 | 1.06 | 1.20 | 1.46 | 2.23 | 2.54 |
| — | +18.8% | -4.4% | -22.9% | -44.4% | -11.9% | -21.8% | -5.4% | +3.2% | -2.0% | +25.5% | +150.6% | +252.0% | +121.3% | +61.0% | -39.0% | -58.1% | -54.8% | -71.1% | -52.5% | -29.7% | |
| P/B Ratio | 1.93 | 3.22 | 2.63 | 2.41 | 3.95 | 4.37 | 4.21 | 5.61 | 7.43 | 4.84 | 6.14 | 7.42 | 9.10 | 654.05 | 9.59 | 5.23 | 4.24 | 4.46 | 4.96 | 6.18 | 7.38 |
| — | -26.4% | -37.5% | -57.0% | -46.8% | -9.7% | -31.4% | -24.4% | -18.4% | -99.3% | -36.0% | +41.8% | +114.5% | +14558.7% | +93.3% | -15.3% | -42.6% | -42.4% | -69.3% | -53.9% | -31.7% | |
| P/FCF | 23.69 | 32.70 | — | 111.99 | 10.31 | 10.28 | 16.06 | 57.78 | 19.36 | 15.22 | 12.06 | — | 33.03 | 17.88 | 25.61 | — | — | 133.44 | — | — | — |
| — | +218.1% | — | +93.8% | -46.7% | -32.5% | +33.2% | — | -41.4% | -14.9% | -52.9% | — | — | -86.6% | — | — | — | +355.0% | — | — | — | |
| EV / EBITDA | — | — | — | — | 8.95 | 8.38 | 13.06 | 22.91 | 24.11 | 16.38 | 9.98 | 20.16 | 19.41 | 17.50 | 15.99 | 161.85 | 31.87 | — | — | — | 37.01 |
| — | — | — | — | -62.9% | -48.8% | +30.9% | +13.7% | +24.2% | -6.4% | -37.6% | -87.5% | -39.1% | — | — | — | -13.9% | — | — | — | — | |
| EV / EBIT | 5.30 | — | — | — | 9.80 | 9.74 | 15.06 | 28.87 | 30.37 | 17.61 | 10.57 | 21.25 | 20.39 | 18.85 | 17.31 | — | 71.09 | — | — | — | 48.44 |
| — | — | — | — | -67.7% | -44.7% | +42.4% | +35.9% | +48.9% | -6.6% | -38.9% | — | -71.3% | — | — | — | +46.8% | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.6% | 79.8% | 69.0% | 70.6% | 83.9% | 83.5% | 81.1% | 81.2% | 81.8% | 81.8% | 82.7% | 84.4% | 84.1% | 81.9% | 83.3% | 82.7% | 80.7% | 82.0% | 82.3% | 83.1% | 84.0% |
| — | -4.5% | -14.9% | -13.1% | +2.5% | +2.2% | -2.0% | -3.8% | -2.7% | -0.2% | -0.6% | +2.1% | +4.2% | -0.1% | +1.2% | -0.5% | -4.0% | -2.3% | +1.3% | -0.9% | -0.2% | |
| Operating Margin | 15.3% | -18.8% | -28.7% | -27.2% | 17.8% | 19.5% | 12.5% | 9.4% | 11.9% | 13.3% | 26.9% | 15.6% | 17.8% | 13.6% | 13.3% | -0.5% | 1.4% | -10.5% | -14.4% | -15.8% | 4.9% |
| — | -196.3% | -328.7% | -390.8% | +50.0% | +46.9% | -53.3% | -40.0% | -33.3% | -2.5% | +101.6% | +3384.2% | +1143.5% | +229.7% | +192.6% | +97.0% | -70.7% | -515.7% | -2295.2% | -38.2% | +120.9% | |
| Net Margin | 11.6% | -13.9% | -23.1% | -18.4% | 12.9% | 14.7% | 9.8% | 8.0% | 8.0% | 9.6% | 20.2% | 10.9% | 61.6% | 10.4% | 1.5% | -7.0% | -0.6% | -12.4% | -16.2% | -17.8% | 3.3% |
| — | -194.7% | -336.4% | -331.2% | +60.7% | +52.9% | -51.7% | -27.2% | -87.0% | -7.8% | +1268.5% | +257.3% | +11136.8% | +183.9% | +109.1% | +61.0% | -117.0% | -235.7% | -522.6% | -27.4% | +113.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.6% | -4.1% | -6.5% | -4.3% | 6.1% | 7.4% | 4.6% | 3.5% | 4.0% | 4.6% | 10.9% | 6.2% | 74.2% | 21.0% | 1.6% | -6.7% | -0.6% | -11.1% | -13.3% | -11.8% | 2.5% |
| — | -155.3% | -241.0% | -222.6% | +54.2% | +58.5% | -57.9% | -42.8% | -94.6% | -77.9% | +600.3% | +192.8% | +13292.6% | +289.5% | +111.7% | +43.4% | -122.8% | -308.1% | -531.0% | -23.6% | +114.6% | |
| ROA | 16.0% | -3.2% | -5.0% | -3.3% | 4.6% | 5.5% | 3.4% | 2.6% | 2.9% | 3.4% | 7.8% | 4.0% | 25.0% | 4.7% | 0.7% | -2.9% | -0.2% | -4.9% | -6.3% | -5.8% | 1.2% |
| — | -158.0% | -246.9% | -226.9% | +56.7% | +60.8% | -56.1% | -34.6% | -88.3% | -26.9% | +1019.9% | +237.0% | +10462.8% | +194.6% | +111.0% | +49.3% | -120.1% | -287.9% | -572.9% | -35.7% | +115.1% | |
| ROIC | 42.3% | -10.2% | -15.2% | -11.3% | 13.9% | 14.4% | 8.0% | 5.4% | 7.4% | 7.3% | 14.4% | 8.4% | 29.8% | 53.5% | 12.9% | -0.4% | 1.4% | -9.6% | -12.9% | -12.0% | 4.8% |
| — | -170.9% | -289.2% | -308.0% | +87.9% | +97.2% | -44.1% | -35.6% | -75.3% | -86.4% | +11.2% | +2158.3% | +2073.7% | +654.1% | +200.4% | +96.6% | -71.5% | -452.6% | -1977.4% | -14.8% | +117.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | — | 0.01 | 0.07 | 0.09 | 0.08 | 0.09 | 0.09 | 0.13 | 0.11 | 0.11 | 0.12 | 0.34 | 36.82 | 0.64 | 0.68 | 0.70 | 0.77 | 0.61 | 0.57 | 0.58 |
| — | — | -91.9% | -21.3% | -31.7% | -27.5% | -25.6% | -26.3% | -61.8% | -99.7% | -82.0% | -81.6% | -52.1% | +4703.8% | +4.0% | +19.5% | +22.3% | +38.4% | +9.2% | -8.1% | +1.5% | |
| Debt / EBITDA | 0.29 | — | — | — | 0.93 | 0.66 | 1.19 | 1.63 | 1.77 | 1.54 | 0.78 | 1.39 | 2.95 | 4.09 | 4.35 | 86.19 | 22.11 | — | — | — | 12.14 |
| — | — | — | — | -47.6% | -57.1% | +51.8% | +17.0% | -40.1% | -62.3% | -82.0% | -98.4% | -86.6% | — | — | — | +82.1% | — | — | — | — | |
| Current Ratio | 4.32 | 4.35 | 5.33 | 5.39 | 4.32 | 4.41 | 4.39 | 4.70 | 4.21 | 4.10 | 3.85 | 3.29 | 3.57 | 3.54 | 3.18 | 3.22 | 3.08 | 2.97 | 3.53 | 3.71 | 3.51 |
| — | -1.2% | +21.5% | +14.9% | +2.6% | +7.3% | +14.1% | +42.8% | +17.9% | +15.9% | +21.2% | +2.1% | +15.9% | +19.4% | -10.0% | -13.2% | -12.1% | -12.7% | +20.8% | +37.2% | +29.2% | |
| Quick Ratio | 3.92 | 3.84 | 4.79 | 4.81 | 3.92 | 3.95 | 3.90 | 4.13 | 3.69 | 3.53 | 3.22 | 2.71 | 3.11 | 3.10 | 2.80 | 2.86 | 2.78 | 2.66 | 3.17 | 3.35 | 3.24 |
| — | -2.7% | +22.9% | +16.3% | +6.4% | +11.9% | +20.9% | +52.4% | +18.4% | +13.6% | +15.2% | -5.4% | +12.1% | +16.6% | -11.7% | -14.6% | -14.2% | -15.0% | +16.4% | +34.3% | +27.5% | |
| Interest Coverage | 38.16 | -35.87 | — | -38.14 | 54.81 | 30.11 | 28.38 | 19.02 | 4.41 | — | 7739.67 | 7.84 | 9.73 | 6.61 | 6.63 | -0.22 | 0.73 | -5.59 | -8.24 | -8.26 | 2.86 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 45 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MDXG stock.
MiMedx Group, Inc.'s current P/E is -25.2x. The average P/E over the last 1 quarters is 16.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
MiMedx Group, Inc.'s current operating margin is 15.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking MiMedx Group, Inc.'s business trajectory between earnings reports.